Stay updated on Uproleselan with Chemotherapy for AML Clinical Trial

Sign up to get notified when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Uproleselan with Chemotherapy for AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T22:26:31.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study content, indicating restricted access to the requested study record.
    Difference
    17%
    Check dated 2026-09-20T19:58:10.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.5 to v3.6.6; this represents a minor update to the page's metadata or display without changing study details.
    Difference
    0.0%
    Check dated 2026-08-30T21:57:52.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision metadata on the page was updated from v3.6.4 to v3.6.5, reflecting a version upgrade. The change does not affect the study data or displayed information.
    Difference
    0.0%
    Check dated 2026-08-09T11:35:03.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The revision tag on the page updated from v3.6.3 to v3.6.4. This indicates a new published version of the page, likely reflecting administrative updates rather than user-facing content changes.
    Difference
    0.0%
    Check dated 2026-07-26T00:11:10.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    The page now shows a new revision tag, v3.6.3, replacing the previous v3.6.2. This appears to be a small maintenance update and does not alter the study information, eligibility criteria, or locations.
    Difference
    0.0%
    Check dated 2026-07-04T13:37:18.000Z thumbnail image

Stay in the know with updates to Uproleselan with Chemotherapy for AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.